While focusing on traditional characteristics such as histological type, grade, and stage of the tumor, we also included information on immunohistochemical markers, which were previously associated with poor prognosis (L1CAM positivity, mutation of p53, loss of hormone receptors ER, PR). This evidence concerns the gene TP53 and neoplasm.